Trial
NCT05492500
A Study of Ponsegromab in People With Heart Failure
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
The TIMI Study Group
Condition
Heart Failure
Intervention
Main cohort (Cohort A): Ponsegromab low dose
Why stopped
Following a prespecified interim analysis, and in consultation with the independent Data Monitoring Committee, the Sponsor terminated the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-18